COThe Cooper Companies COO · NASDAQ
$57.94 +0.94% (+$0.54)
- Market cap
- $11.2B
- Enterprise value
- $13.6B
- P/E
- 19.6x
- Forward P/E
- 12.3x
- PEG
- -
- P/S
- 2.6x
- P/FCF
- 123.6x
- EV/EBITDA
- 16.7x
- ROIC
- 5.9%
- Gross margin
- 64.8%
- Net margin
- 13.5%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 2.9x
- Beta
- 0.83
- Free float
- 99.4%
About the company
The Cooper Companies, Inc. (COO) is an American company operating in the healthcare equipment and products industry. The company focuses on manufacturing and distributing contact lenses, surgical instruments, and diagnostic devices. Its main divisions include CooperVision, which specializes in contact lenses, and CooperSurgical, which focuses on women's health and reproductive medicine. The Cooper Companies emphasizes on innovation and product quality, positioning it among the leading companies in its sector. With the increasing demand for healthcare equipment and improving health awareness, investing in The Cooper Companies, Inc. (COO) shares may represent an interesting opportunity for investors interested in the healthcare industry and seeking a diversified company with an extensive portfolio of healthcare products.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert G. White
Employees
15,000
Headquarters
San Ramon
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number